Cyclacel Pharmaceuticals, Inc. (CYCC)

Theseus Pharmaceuticals Revenue

Cyclacel Pharmaceuticals had revenue of $14.00K in the twelve months ending March 31, 2025, down -96.88% year-over-year. In the year 2024, Cyclacel Pharmaceuticals had annual revenue of $43.00K, down -89.76%.

• Revenue (ttm): $14.00K
• Revenue Growth: -96.88%
• P/S Ratio: 1,099.72
• Revenue / Employee: $1,167
• Employees: 12
• Market Cap: 15.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.00K	-377.00K	-89.76%
Dec 31, 2023	420.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.